Network mirroring for drug repositioning

[31] Modell JW(2006)Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 1306-D922

[32] Blat IC(1980)Prevalence of urinary incontinence Br Med J 281 1243-undefined

[33] Wrobel MJ(2011)New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition J Mol Neurosci 45 696-undefined

[34] Lerner J(2015)Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies J Neurochem 133 266-undefined

[35] Brunet J-P(2006)Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′ dG Neurology 66 250-undefined

[36] Subramanian A(2005)Entrez Gene: gene-centered information at NCBI Nucleic Acids Res 33 D54-undefined

[37] Ross KN(2010)T3DB: a comprehensively annotated database of common toxins and their targets Nucleic Acids Res 38 D781-undefined

[38] Keiser MJ(2006)DrugBank: a comprehensive resource for in silico drug discovery and exploration Nucleic Acids Res 34 D668-undefined

[39] Setola V(2012)ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res 40 D1100-undefined

[40] Irwin JJ(2008)SuperTarget and Matador: resources for exploring drug-target relationships Nucleic Acids Res 36 D919-undefined

[31] Modell JW(2006)Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 1306-D922

[32] Blat IC(1980)Prevalence of urinary incontinence Br Med J 281 1243-undefined

[33] Wrobel MJ(2011)New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition J Mol Neurosci 45 696-undefined

[34] Lerner J(2015)Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies J Neurochem 133 266-undefined

[35] Brunet J-P(2006)Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′ dG Neurology 66 250-undefined

[36] Subramanian A(2005)Entrez Gene: gene-centered information at NCBI Nucleic Acids Res 33 D54-undefined

[37] Ross KN(2010)T3DB: a comprehensively annotated database of common toxins and their targets Nucleic Acids Res 38 D781-undefined

[38] Keiser MJ(2006)DrugBank: a comprehensive resource for in silico drug discovery and exploration Nucleic Acids Res 34 D668-undefined

[39] Setola V(2012)ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res 40 D1100-undefined

[40] Irwin JJ(2008)SuperTarget and Matador: resources for exploring drug-target relationships Nucleic Acids Res 36 D919-undefined